Log In
BCIQ
Print this Print this
 

Collatamp G

  Manage Alerts
Collapse Summary General Information
Company Innocoll Holdings plc
DescriptionFully resorbable, gentamicin-impregnated collagen sponge
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard Indication Infectious (unspecified)
Indication DetailsPrevent surgical site infections
Regulatory Designation
PartnerAralez Pharmaceuticals Inc.;
EUSA Pharma Ltd.;
Theramed Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$146.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/05/2016

$146.0M

Undisclosed

0

Get a free BioCentury trial today